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Abstract
Background: Oleosin is a plant protein localized to lipid droplets and endoplasmic reticulum of plant cells. Our idea was to
use it to target functional secretory proteins of interest to the cytosolic side of the endoplasmic reticulum of mammalian
cells, through expressing oleosin-containing chimeras. We have designed this approach to create cellular models deficient
in vitamin B12 (cobalamin) because of the known problematics associated to the obtainment of effective vitamin B12
deficient cell models. This was achieved by the overexpression of transcobalamin inside cells through anchoring to oleosin.
Methodology: chimera gene constructs including transcobalamin-oleosin (TC-O), green fluorescent protein-transcobalamin-
oleosin (GFP-TC-O) and oleosin-transcobalamin (O-TC) were inserted into pAcSG2 and pCDNA3 vectors for expression in sf9
insect cells, Caco2 (colon carcinoma), NIE-115 (mouse neuroblastoma), HEK (human embryonic kidney), COS-7 (Green
Monkey SV40-transfected kidney fibroblasts) and CHO (Chinese hamster ovary cells). The subcellular localization, the
changes in vitamin B12 binding activity and the metabolic consequences were investigated in both Caco2 and NIE-115 cells.
Principal findings: vitamin B12 binding was dramatically higher in TC-O than that in O-TC and wild type (WT). The
expression of GFP-TC-O was observed in all cell lines and found to be co-localized with an ER-targeted red fluorescent
protein and calreticulin of the endoplasmic reticulum in Caco2 and COS-7 cells. The overexpression of TC-O led to B12
deficiency, evidenced by impaired conversion of cyano-cobalamin to ado-cobalamin and methyl-cobalamin, decreased
methionine synthase activity and reduced S-adenosyl methionine to S-adenosyl homocysteine ratio, as well as increases in
homocysteine and methylmalonic acid concentration.
Conclusions/Significance: the heterologous expression of TC-O in mammalian cells can be used as an effective strategy for
investigating the cellular consequences of vitamin B12 deficiency. More generally, expression of oleosin-anchored proteins
could be an interesting tool in cell engineering for studying proteins of pharmacological interest.
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Introduction
Targeting functional secretory proteins to cell membranes may
be a useful tool for research in cell biology, genetics, and disease
treatment. Previously, various strategies have been used to redirect
or anchor either secretory or intracellular proteins to cell surface to
uncover novel protein function and properties [1,2]. An alternate
strategy is to localize/limit functional secretory proteins to the
intracellular membrane in order to study the consequences of this
and eventually reveal the associated molecular mechanisms.
Oleosin is a plant oil body protein targeted by its central
hydrophobic to the endoplasmic reticulum (ER) [3,4]. Evidence
has indicated that when expressed in plant tissues lacking oil body,
oleosin accumulates in ER membrane [3,5]. The localization
pattern is conserved even when it is heterologously expressed in
eukaryotic cells, including those of mammalian origin [6]. Our idea
was therefore that oleosin could be a tool for targeting secreted
proteins to the cytoplasmic side of the ER through the making of
oleosin-fused proteins. We first tested this method in cultured
mammalian cells using transcobalamin (TC), a secretory protein,
and the green fluorescent protein (GFP)-fused TC-oleosin
(figure 1A). TC is the secreted carrier protein of vitamin B12 that
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6325binds to vitamin B12 with the highest specifity and affinity [7,8].
Anchoring TC to ER was expected to sequester vitamin B12 within
the cells (figure 1A). The minute amount of vitamin B12 needed by
cells can be provided by the receptor endocytosis of TC-bound B12
from blood (TC) [7,8]. The TC-bound B12 that can be provided to
cells by fetal calf serum is in order of 5 fmol/ml and the apical
release of endogenous TC in order of 2 fmol/cm2/h in confluent
caco-2 cells cultivated in standard conditions [8]. Intracellular, B12
is converted into methyl-cobalamin and adenosyl-cobalamin, the
cofactors of the cytoplasmic methionine synthase (EC 2.1.1.13) and
the mitochondrial enzyme L-methylmalonyl-coenzyme A mutase
(EC 5.4.99.2), respectively (figure 1A).
Figure 1. (A) Experimental model of vitamin B12 intracellular sequestration by the transcobalamin-oleosin chimeric protein. (B) The schematics of
the transcobalamin-oleosin (TC-oleosin) and oleosin-transcobalamin (oleosin-TC) cDNA constructs in the plasmid pAcSG2.
doi:10.1371/journal.pone.0006325.g001
Oleosin-Fused Transcobalamin
PLoS ONE | www.plosone.org 2 July 2009 | Volume 4 | Issue 7 | e6325We are interested in studying the effect of B12 deficiency in an
effective cultured cell models [10,11], since it is known that only a
minute amount of vitamin B12 is needed by animal cells and in
normal culture systems a sufficient quantity of it is provided by
either the autocrine synthesis of the TC or by the fetal calf serum
added to the culture medium for the maintainess of the cellular
growth [8,12]. This is why in normal culture system vitamin B12-
dependent metabolic pathways continue to function even in the
absence of exogenously added vitamin B12 [8,12]. Up to now, no
efficient vitamin B12 deficient cell model exists for mechanistic
studies, except the use of anti-TC antibodies for impairing the
growth of leukemia cells [12]. In humans, two crucial metabolic
pathways require vitamin B12 as cofactors [13]. One rearranges
MMA to succinyl CoA, and is catalyzed by methylmalonyl CoA
mutase in mitochondria. The other produces methionine, the
precursor of S-adenosyl methionine (SAM), by remethylation of
homocysteine (Hcy) and is catalyzed by methionine synthase in the
cytoplasm. SAM is the universal methyl donor of the transmeth-
ylation reactions involved in methylation of DNA, lipids and
proteins. Vitamin B12 deficiency leads to the impairment of these
pathways, which results in accumulation of MMA and Hcy,
megaloblastic anemia and central nervous system abnormalities. It
is not clear if vitamin B12 exerts its function only through its role
as the co-factor of two enzymes mentioned above. For example, it
influences the status of pro-inflammatory cytokines in central
nervous system and modulates the translation of methionine
synthase by the internal ribosome entry site (IRES) [14,15]. These
examples underscore the need to establish effective cell models for
the studying the molecular mechanisms of vitamin B12. We
present below several lines of evidence that validate the
localization of TC-Oleosin chimera in endoplasmic reticulum of
the cells in producing intracellular sequestration of vitamin B12.
Results
Thepeanutoleosin sequencewasdetermined previously[9].This
oleosin was used as a template for constructing the oleosin related
plasmids. We ascertained first that oleosin gene could be expressed
properly in animal cells by subcloning the peanut gene into pSP64
polyA plasmid for in vitro expression in rabbit reticulocyte lysate.
The expressed
14C oleosin was immunoadsorbed by rabbit anti-
oleosin antibody on Protein A-SepharoseH. After SDS-PAGE, the
autoradiograph showed a
14C-labeled band at the same 17 kDa
molecular size as the native protein (Figure 2B). We then evaluated
the expression of the chimeras using pAcSG2 and pcDNA3
plasmids in sf9 insect cells and in mammalian cell lines, respectively.
The cells were transiently transfected with each of the recombinant
plasmids to quantify the vitamin B12 binding in both intact and
lyzed cells. The characterization of vitamin B12 binding of TC-O
chimera in membrane fraction of the lyzed sf9 cells showed a Ka of
,0.02 pmol/L (Figure 2B). Comparing the lyzed and intact cells
expressingTC-Ochimera,weunrevealedatwelve-folddifferencein
the B12 binding capacity of the Caco2 cells, with the lyzed cells
displaying the much higher binding capacity (Figure 3A). We also
found a dramatic difference in cobalamin binding between the O-
TC and the TC-O chimeras in intact and lysed Caco2 cells
(Figure 3A,B). The same difference was found in sf9 and NIE-115
cells (data not shown). The binding B12 capacity in the membrane
fraction was similar in O-TC transfected cells and WT cells treated
by sonication, suggesting it was not influenced by the disruption of
the ER lumen (1200649 vs. 1180668 cpm/mg protein). The
vitamin B12 binding ability of transfected cells remained stable
during continuing culture condition for 15 days (Figure 3B). The
binding difference between intact and lyzed TC-O cells was
similarly evidenced at days 5–7 and days 10–15, indicating that
Figure 2. (A) Characterization of the recombinant oleosin (top) and transcobalamin-oleosin (bottom) chimeric proteins; SDS-PAGE (12.5%) (lanes 1–
3, 10) and Western blot (WB) (lanes 4–9) of subcellular fractions (pellets and supernatant from differential centrifugation) from Sf9 cells infected with
recombinant baculovirus expressing either peanut oleosin or the transcobalamin-oleosin chimeric protein. Lanes 1, 4, 7: 900 g pellet, lanes 2, 5, 8: 100
000 g supernatant, lanes 3, 6, 9: 100 000 g pellet, lane 10: 85 ng purified peanut oleosin and lane 11: autoradiography of [
14C]-leucine-labeled oleosin
expressed in rabbit reticulocyte lysate. (B) Saturation curve of vitamin B12 binding of transcobalamin-oleosin (TC-O) in membrane fraction of lysed
sf9 insect cells and corresponding Scatchard plot (inlet).
doi:10.1371/journal.pone.0006325.g002
Oleosin-Fused Transcobalamin
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nous structures in exponential and stationary growth phases. With
confocal microscopy, we subsequently examined the expression of
TC-O in Caco2, NIE-115, HEK, COS-7 and CHO cells using
GFP-TC-O (figure 4A). The co-localization of the GFP-TC-O with
the ER-target red fluorescent protein suggested that TC-O
expression is limited to the reticulum. The localization of the
chimera inthemembranes of endoplasmic reticulumwasconfirmed
by itsimmunological detection with a Goldconjugate inmicroscopy
electron microscope immunocytochemistry (figure 4B). The expres-
sion of TC in ER did not modify the cell targeting of multiligand
proteins that share affinity for TC. In particular, the localization of
megalin was maintained in the apical surface of caco-2 cells, in
confocal microscopy. In addition, we did not observe any co-
localization of megalin and calnexin, in confocal microscopy of
Caco2 cells expressing the chimera (figure 4B,C). Further confocal
microscopic examination with anti-transcobalamin immunofluores-
cence of the COS-7 transiently transfected with the pCDNA
constructs confirmed the results; in cells transfected with pCDNA-
TC-O and pCDNA-O-TC, TC was mainly localized in intracel-
lular membranes; in contrast, tranfection with pCDNA3-TC
produced a diffused expression of TC in the whole cytoplasm while
no TC was detected in cells transfected with pCDNA3-oleosin and
empty pCDNA3 (figure 5A). More confocal analysis revealed the
co-localization of GFP-TC-O with calreticulin, a protein of ER
membrane [16] but not with golgin 97, a protein of Golgi apparatus
[17]; these results asserted the ER localization of the oleosin-
anchored proteins.
We then examined the consequences of the B12 intracellular
sequestration in stably transfected Caco2 and NIE-115 cells. By
adding radioactive [
57Co]-labeled B12 (cyano-cobalamin) to the
culture medium, a dramatic decrease in its intracellular conversion
Figure 3. (A) Vitamin B12 binding capacity (cyano[
57Co]Cbl) of membrane fraction (100 mg proteins per assay) from Caco2 cells, 72 hrs after
transient transfection with various recombinant pcDNA3 plasmids expressing transcobalamin (TC), oleosin (O) and the chimeric proteins
transcobalamin-oleosin (TC-O) and oleosin-transcobalamin (O-TC). (B) Vitamin B12 ([57Co]-labeled) binding capacity of Caco2 cells of the intact and
lyzed (Caco2 cells were lysed prior to the addition of vitamin B12 or used intact), at days 5–15 of culture, after stable transfection with a recombinant
pcDNA3 plasmid expressing the chimeric protein transcobalamin-oleosin. Exponential and stationary phases were evaluated at days 5–7 and days
10–15, respectively. Bars from left to right for each time: non-transfected intact cells, non-transfected lysed cells, TC-O transfected intact cells, TC-O
transfected lysed cells.
doi:10.1371/journal.pone.0006325.g003
Oleosin-Fused Transcobalamin
PLoS ONE | www.plosone.org 4 July 2009 | Volume 4 | Issue 7 | e6325Figure 4. (A) Confocal microscopic examination of the localization of the green fluorescent protein-transcobalamin-oleosin (GFP-TC-O) chimeric
protein 24 hrs after transient transfection of Caco2, human embryonic kidney cells (HEK293), Chinese hamster ovary (CHO) and COS-7 cells. In Caco2
cells, GFP-TC-O co-localization was detected with an ER-targeted red fluorescent protein (pDsRED2-ER, Clontech USA) (merged). (B) Left: Transmission
electron microscope examination of the chimera detected immunologically by a Gold conjugate (arrows) (left). Calibration bar=0.1 mm.
Abbreviations: mb, membrane, ER, endoplasmic reticulum. Middle: confocal image of immunolabeling of megalin in apical surface of O-TC caco-2
cells. Right: relative fluorescence intensity (low, red; high: blue) of megalin on apical area. Calibration bar=18 mm. (C) Left and middle: Confocal
image of immunolabeling of megalin (Alexa488 coded in green, left channel) and calnexine (Alexa555 coded in cyan, right channel). Right: Merged.
Calibration bar=18 mm.
doi:10.1371/journal.pone.0006325.g004
Oleosin-Fused Transcobalamin
PLoS ONE | www.plosone.org 5 July 2009 | Volume 4 | Issue 7 | e6325Figure 5. (A) Confocal microscopic examination of transcobalamin in COS-7 cells transiently transfected with lipofectamine. The cells were
transfected with one of the following pCDNA3-plasmids: TC-O coding for transcobalamin-oleosin (TC-O), O-TC coding for oleosin-transcobalamin (O-
TC), TC coding for transcobalamin (TC), O coding for oleosin (O), and the empty plasmid (pCDNA3). The immuno-fluorescence was done with a goat
polyclonal antibody to TC and a donkey antigoat IgG fluorescin labeled. Cell nuclei were counterstained with Hoechst 33258. Calibration
bars=20 mm. (B and C) Co-localization of the protein GFP-TC-O with endoplasmic reticulum in transient transfected Cos-7 cells using lipofectamine.
The cells were transfected with the plasmid GFP-TC-O coding for GFP-transcobalamin-oleosin (GFP-TC-O). The immuno-fluorescence was done with a
mouse monoclonal antibody to the human golgin-97 or a rabbit polyclonal antibody to calreticulin. The secondary antibodies were a donkey IgG
anti-mouse TRITC labeled or a donkey IgG anti-rabbit TRITC labeled. Cell nuclei were counterstained with Hoechst 33258. Calibration bars=20 mm.
doi:10.1371/journal.pone.0006325.g005
Oleosin-Fused Transcobalamin
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the cytosolic and the mitochondria enriched fractions of the TC-O
expressing cells (Figure 6A). LC-MS/MS analysis of the cellular
homocysteine content and the secreted methylmalonic acid
associated with TC-O cell culture showed significant changes,
compared to the WT cells (Figure 6B, p,0.0001 and p,0.0001,
respectively); a reduction in the S-adenosylmethionine (SAM)/S-
Adenosylhomocysteine (SAH) ratio was also observed (p=0.0023,
compared with wild type cells) (Figure 6C). We scrutinized the
activity of the B12-dependent cytosolic enzyme methionine
synthase and found a largely decreased methionine synthase
activity in both TC-O transfected Caco-2 and NIE-115 cells
(Figure 6D). These results indicate, at least in the cell lines tested,
that the cytosolic bioactive B12 (methyl-cobalamin) and the B12
dependent synthesis of methionine, key amino acid needed for cell
growth, are diminished in TC-O cells.
Discussion
Oleosin is a protein originated from plant that has been used as
a carrier to produce protein of biological interest in plants [18,19].
Our approach here in using oleosin as an intracellular anchor for
secretory protein in mammalian cells is oriented from another
perspective, focusing more on the targeting ability of the protein
oleosin. The technology is meant to work in the mammalian
system [6]. Because of its unique structure, Oleosin serves as an
interfacial molecule to stabilize the oil droplets within the
hydrophilic cytosol. In Plants, it is targeted to oil bodies via the
endoplasmic reticulum and consists of a lipid-submerged hydro-
phobic domain H that is flanked by two cytosolic hydrophilic
domains N and C [3,4,5]. Molecular modeling of oleosins has
suggested a configuration with exposing N- and C-terminal
domains in cytosol and a central hairpin conformation that
anchors the molecule within the lipophilic core [3,4,5,20]. This
configuration allows for the positively charged residues within the
flanking domains of the oleosin to interact with the negatively
charged phosphate groups of the oil body phospholipid monolayer
[20]. The interaction between the oleosin and the phospholipid
monolayer causes the surface of the oil body to become enveloped
in a protein shell [20,21]. This unique amphipathic structure of
the oleosin molecule appeared to be maintained in mammalian
cells [6]. This was confirmed in our model, where the fusion
Figure 6. (A) Intracellular conversion of exogenous [
57Co]-labeled B12 (cyano-cobalamin, CN-Cbl) into methyl-cobalamin (Me-Cbl) and
ado-cobalamin (Ado-Cbl) in the cytosolic and mitochondria enriched fractions. (B) Homocysteine (Hcy) and methylmalonic acid (MMA)
concentrations. (C) S-adenosylmethionine/S-Adenosylhomocysteine ratio (SAM/SAH) in TO and wild type NIE-115 cells. (D) Activity of methionine
synthase in TO transfected and wild type NIE-115 and Caco2 cells in exponential growth. Mean6S.D. of sextuplet assays are given. ****: p,0.0001, **:
p,0.001, *: p,0.001.
doi:10.1371/journal.pone.0006325.g006
Oleosin-Fused Transcobalamin
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reticulum membrane, as illustrated by the B12 binding experiment
in lyzed cells (Figure 3).
The chimeric GFP oleosin TC protein was colocalized with the
ER-targeted red fluorescent protein and the ER-bound calreticulin
(Figure 4, 5). These results indicated that adding another protein
to the N-terminal end of the oleosin protein (through the making a
fusion protein) did not alter its intracellular localization. These
results confirm previous structural-function studies which suggest
the central hydrophobic domain to be necessary for ER targeting,
while the N- or C-terminal domain being of no consequence to its
membrane localization [6,20,21]. Oleosin locates also in oil bodies
when ectopically expressed both in yeast and mammalian cells,
which are able to produce them [4,5,6].
The rationale behind expressing this oleosin fusion protein was
to immobilize TC within cells. TC, under normal physiological
condition, is synthesized by various cells including polarized
epithelial cells such as Caco2 cell and is secreted into plasma in a
constitutive manner [7]. Functionally, the plasmatic TC is to bind
the circulating vitamin B12. The bound TC then is internalized
via receptor-mediated endocytosis [7]. Depending on the cell
types, the TC could either be degraded and the released vitamin
B12 utilized, or exported out untouched via transcytosis [8]. We
expected that the over expression of this immobilized vitamin B12
binding protein would serve as an intracellular cage for vitamin
B12. Because the requirement of vitamin B12 for growth and
differentiation, although essential, is extremely low, with uncon-
trollable sources of vitamin B12 in cell culture, one cannot easily
evaluate under classical experimental condition how a change in
the vitamin B12 level affects cell functions [12]. For example, 10%
fetal calf serum provides about 5 fmol/ml of TC bound B12 in our
cell culture conditions of caco-2 cells [12]. The endogenous
synthesis of TC may also help to internalize the vitamin B12
provided by the culture medium [12]. With the expression of TC-
O, we were able to observe the metabolic consequences of vitamin
B12 intracellular sequestration, namely a decrease in the
intracellular conversion of B12 and the subsequent reduced
methionine synthase activity which resulted in increases of Hcy
and MMA, and a decrease SAM/SAH ratio. The inclusion of
oleosin appeared necessary since evidently, the expression of TC
itself offered no significant increase in the amount of vitamin B12
sequestered within cells (Figure 3). We also demonstrated the
importance of the position in which oleosin was integrated in the
chimeras. TC-O was a very efficient chelator of cobalamin while
O-TC was no different than the either wild type non-transfected
cells or cells expressing TC alone. This could indicate that
integration of TC in the N-terminal of the oleosin impaired the
B12 binding capacity of the chimer protein, probably by
modifying the conformation of the C-terminal domain of TC
[22]. Indeed, TC has a two-domain architecture, with an N-
terminal barrel and a smaller C-terminal domain, vitamin B12
being buried inside the domain interface [22]. Another hypothesis
could be that the TC part of the O-TC chimera was expressed in
the lumen of reticulum and the TC part of the TC-O chimera in
the cytosolic face. However, this hypothesis disagrees with the
topology of oleosin in reticulum membrane, since oleosin adopts a
unique conformation in which the H domain resides completely
within the lipid bilayer and is flanked by the hydrophilic N and C
domains facing the cytosol [23,24,25]. Mutagenesis experiments
showed that reticulum membrane topology of oleosin is con-
strained by its long hydrophobic H domain rather than by the N
and C domains [23]. In addition, deletion of the N or C domains
indicated that the H domain is the only critical component for
reticulum targeting [25]. Our results are consistent with these
data. The B12 binding capacity of the membrane fraction was
similar in O-TC transfected cells and WT cells after sonication of
cell lysate, a treatment that produces a disruption of reticulum
lumen. This suggested that the lack of intracellular B12 binding
capacity in O-TC tranfected cells was not related with a
orientation of the TC part of the chimera in the ER lumen.
Finally, our plasmid constructs included the TC sequence without
its N-terminal signal peptide at the 39 end of the oleosin sequence,
making the translocation of the C domain-TC part of the chimera
in the reticulum lumen unlikely [24].
Since TC is a ligand of megalin and megalin is an actor of B12
uptake in epithelial cells [26], a possible effect of the chimera in
caco-2 cells could be to retain megalin in the endoplamic
reticulum. The subsequent effects would be to influence its apical
expression and B12 uptake. Our results in confocal analysis of
megalin showed that its localization was maintained in the apical
surface of caco-2 cells and that it was not retained in the
endoplasmic reticulum (figure 4B,C), making unlikely the presence
of an interaction with the chimera.
Our model was adapted to examine the complex consequences
of B12 impaired metabolism in cells, in particular to investigate
whether cobalamin has other effects than through the two known
B12-dependent reactions (methionine synthase MS and MMA
mutase). Alternative strategies for producing cell deficiency in
vitamin B12 would be more focused on one of the many actors
involved in the internalization, intracellular transport and
metabolism of the vitamin. Among these strategies are the uses
of anti-TC antidoby [12] and of siRNA. The latter should be
targeted and equally efficient on the different actors involved in
endocytosis of vitamin B12. In the case of digestive epithelial cells,
these actors are cubilin, amnionless, megalin, TC receptor and
asialoglycoprotein receptor [26,27,28]. In addition, the ‘‘knocking
down’’ approaches produce pitfalls related to efficiency, stability,
specificity, side effects [29].
In conclusion, oleosin has already been used as a tool of
molecular farming for the production of pharmaceutical proteins
in plants. Our approach was to use it as an anchor for secretory
proteins in cell culture and in vivo, as illustrated by the functional
expression of TC-oleosin. The heterologous expression of TC-O
in mammalian cells can be an effective strategy for investigating
the cellular consequences of vitamin B12 deficiency, in particular
in relation with epigenetics, neurodegenerative mechanisms and
carcinogenesis, using the anti-TC at a dilution of 1:60 dilution.
More generally, this strategy may be used with other functional
proteins.
Methods
Reagents
Methionine, homocysteine, homocystine, homocysteine-thiolac-
tone, L-cystine, S-adenosyl-methionine, hydroxocobalamin, pro-
tease inhibitor cocktail and Neutral Red were obtained from
Sigma (St Louis, MO, USA). Cyanocobalamin was provided by
Aguettant (Lyon, France). [
14C]Methyl tetrahydrofolate was
purchased from Amersham Biosciences (Orsay, France) with a
specific activity of 57 mCi/mmol. Dulbecco’s Modified Eagle’s
Medium and Dulbecco’s Modified Eagle’s Medium without L-
methionine were from Gibco Invitrogen Corporation (Cergy
Pontoise, France). All other chemicals were of cell culture grade.
Oleosin cDNA preparation
cDNA of transcobalamin gene (TC) was prepared as described.
8
The peanut oleosin gene (O) sequence was previously determined
by us [9]. The oligo(dT)15-primed cDNA produced by AMV
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total RNA from mature seeds was used for PCR amplification of
the complete peanut oleosin open reading frame. Primers for PCR
were designed to include a PstI site and a vertebrate Kozak
consensus sequence at the 59 end and a XbaI site at the 39 end of
the coding sequence.
Expression in rabbit reticulocyte lysate
The peanut gene 560-bp PCR product with the Kozak
consensus sequence was subcloned into the EcoRI/PstI restriction
sites of pAcSG2 vector for in vitro expression in rabbit reticulocyte
lysate (TNTH SP6 Coupled Reticulocyte Lysate System, Pro-
mega). The expressed
14C oleosin was immunoadsorbed by rabbit
anti-oleosin antibody on Protein A-SepharoseH CL-4B (Pharma-
cia, Saint-Quentin en Yvelines, France).
Expression in the Sf9-baculovirus system
The recombinant baculovirus (1 mg) was used for translation of
recombinant pAcSG2 plasmids by an Sf9-baculovirus expression
system. The cells were infected with the recombinant virus in 75
cm
2 Petri plates (15.10
6 cells per plate, 3.5 ml of virus dilution in
culture medium with MOI at 10). They were collected 72 hours
after infection, sonicated 2 times for 20 s using a cell disruptor (B-
30, Branson Sonic Power Co., USA) and subjected to fractionation
at 4uC by a two-step centrifugation at 900 g for 3 min and at
100,000 g for 1 hr, respectively. The 100,000 g pellet and
supernatant corresponded to the membrane-enriched fraction
and to the cytosol fraction respectively.
In vitro expression in mammalian cells
The cDNA from the oleosin gene and the transcobalamin gene
were ligated into the BamHI/XbaI site of a pcDNA3 vector
(Invitrogen, Cergy Pontoise, France) to generate pTC-O. The
resulting plasmid contained the cytomegalovirus (CMV) promoter,
the Kozac sequence, a polylinker cloning site containing the
transcobalamin-oleosin (TC-O) sequence, and a SV40 polyade-
nylation signal. This expression cassette was flanked by resistance
genes directed towards ampicillin and neomycin. For pCDNA3-
oleosin, a PCR product, which included a 59 EcoRI site and a 39
XbaI site around the oleosin sequence, was inserted into the
corresponding MCS sites of the vector. For TC-O, the PCR
product containing the complete human TC coding region
without its N-terminal signal peptide and its stop codon was
inserted at the 59 end of the oleosin sequence between the BamH1
and EcoRI sites of the vector. For O-TC, the oleosin coding
sequence was first inserted without its stop codon in pCDNA3
between the BamH1 and EcoRI sites; the TC sequence without its
N-terminal signal peptide was then inserted at the 39 end of the
oleosin sequence at the EcoRI/XbaI sites. For green fluorescent
protein-TC-O (GFP-TC-O), the PCR product containing BamHI
sites at both the 59 and 39of the GFP without its terminal stop
codon was inserted into the pCDNA3-TC-O. The plasmid was
selected based on the expression of green fluorescence upon
transfection in cells. The cell lines were transfected with the pTC-
O and pO-TC plasmids by the Exgen method (Euromedex,
France). Two micrograms of plasmid DNA solution was added to
the Exgen solution (100 pmol in 150 mM NaCl solution) by slow
dropwise addition with continuous mixing. The resulting com-
plexes were incubated at room temperature for 10 min before
incubation with cells. 48 h after transfection, cells were sub-
cultured and selected with 1.1 mg/ml of G418. After 3 weeks of
selection, the clones were isolated and amplified in the presence of
1.1 mg/ml G418. To confirm the expression of TC-O and O-TC
fusion proteins by cells, cellular RNA was isolated from the cells.
Cells were rinsed with PBS and directly extracted with the RLT
buffer (300 L/well) of the RNeasy kit from QIAGEN (Courta-
boeuf, France), which includes treatment with RNase-free Dnase
(QIAGEN, Courtaboeuf, France), and then subjected to RT-PCR
using the cloning primers described above: Oleosin, sense: 59-
CGC GGA TCC ACC ATG GCT ACT GCT ACT GAT CGT-
39, antisense: 59-CGC GGA TCC TTA TGA TGA TGA CCT
CTT AAC ATC-39; TC-O, sense: 59-CCC CTA CTT AAC CTC
CGT GA-39, antisense: 59-GGA GAG GAG CAA CAG AGT
GC-39; O-TC: sense: 59-CGA CAG GTA CAT GGG ACG AC-
39, antisense: 59-CCT AGG AGG CAC TGC TGG TA-39; GFP-
TC-O, sense: 59-ATG CTG AGC AAG GGC-39, antisense: 59-
CTT GTA CAG CTC GTC-39. RT-PCR was performed using
the Qiagen omniscript Reverse Transcription (Courtaboeuf,
France) and Taq platinum (Invitrogen, Cergy Pontoise, France)
according to the manufacturer’s instruction.
Cell culture conditions
Caco2/TC7 (human colon adenocarcinoma), COS-7 (immor-
talized kidney cells of the African green monkey), CHO (Chinese
hamster ovary) and HEK (human embryonic kidney) were
cultivated in Dulbecco’s modified Eagle’s medium (DMEM)
containing 5% fetal bovine serum (FCS). The Caco-2/TC7
polarized cells are cloned cells established from the human
enterocyte-like Caco-2 cell line [31]. NIE 115 mouse neuroblas-
toma cells chosen here as a neuronal model [32] were cultured in a
complete growth medium containing 90% Dulbecco’s modified
Eagle’s medium with 4.5 g/L glucose (supplemented with sodium
pyruvate) and 10% fetal bovine serum. The cells were studied in
exponential growth and stationary phases. Cell number was
measured by the Dye uptake method using Neutral Red cell
incorporation. The results were expressed as the percentage of the
maximal O.D. value.
Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and immunoblots of
recombinant proteins
were performed using a Mini-protean II electrophoresis unit
(Bio-Rad, Hercules, CA, USA). The stacking and the separating
gel contained 4% and 12% of acrylamide, respectively. Proteins
were separated for 2 hours at 125 V in 25 mM Tris –HCl
(pH 8.3), 0.192 M glycine, 0.1% SDS (w/v) and electrotransferred
onto nitrocellulose membrane (0.2 mm, Bio-Rad) in 25 mM Tris
buffer containing 192 mM glycine and 20% (v/v) methanol
(pH 8.3), using a Trans-blot semi-dry transfer cell (Bio-Rad)
during 30 minutes at 15 V. The membrane was blocked by
incubation in 20 mM Tris-HCl (pH 7.4), 0.15 mM NaCl (TBS),
3% (w/v) BSA for 2 hours at room temperature and was then
washed 2 times in 20 mM Tris-HCl buffer containing 0.15 M
NaCl (TBS) with 0.05% (v/v) Tween 20. Nitrocellulose was then
probed overnight with the anti-oleosin polyclonal rabbit antibody
produced and tested by the laboratory (diluted 1:10 in TBS with
0.1% Tween 20). Anti rabbit HRP-IgG (diluted 1:5000, Sigma, St
Louis, MO, USA). was used for detection with ECL PLUS reagent
(Amersham, UK).
Measurement of binding to radiolabeled cobalamin
Confluent cells were rinsed twice with Dulbecco’s modified
Eagle medium (DMEM) without the addition of FCS. The cells
(10
6 per assay) were then incubated with 0.48 kBq of [
57Co]-
labeled vitamin B12 (ICN Pharmaceuticals, Orsay, France) for 20
minutes at 4uC. They were rinsed three times with PBS prior to
being counted. The resulting radioactivity in the cell pellet was
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were used to report the amount of B12 bound to the intact cells. In
a parallel series, the cells were lyzed at 4uC in a saline buffer TBS
with the presence of protease inhibitors by passing trough a 20-
gauge needle fitted to a 1 mL syringe during one minute. Half of
the samples were sonicated 3 times for 10 s using a cell disruptor
(B-30, Branson Sonic Power Co., USA). After centrifugation
(18,000 g, 4uC) for 30 min the cell pellets were incubated with
0.48 kBq of [
57Co]-labeled vitamin B12 during 20 minutes at 4uC.
After three rinses with TBS, partition of radioactivity was
determined after centrifugation by measuring [
57Co]-Cbl found
in the pellet vs. that remaining in the supernatant using a gamma-
counter (LKB, Wallac, USA). The variation coefficients of the
chimer expression (radioactive B12 binding in membrane fraction)
within and between the different series of experiments were lower
than 20%.
Intracellular location of the chimers by immuno-
histochemistry
Transiently transfected COS-7 cells were used to show TC
protein expression and its cellular localization. For immuno-
staining, cultured cells were washed once with PBS and fixed with
4% para-formaldehyde and permeabilized with PBS-0.1 Triton X-
100 for 30 min. After blocking the nonspecific binding sites with
5% horse serum dissolved in PBS–0.1% Triton X-100 for 30 min
at room temperature (RT), the cells were incubated with the
primary antibody over night at 4uC. The primary antibodies were,
a goat polyclonal antibody anti-TC (1:50 dilution; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), a mouse monoclonal
antibody anti-human golgin-97 (1:50 dilution; Molecular Probes
Inc, Eugene, OR, USA) and a rabbit polyclonal antibody anti-
calreticulin (1:100 dilution; Bioreagents, Golden, CO, USA). After
washing with PBS, cells were incubated for 2 h at RT with the
suitable secondary antibody. These antibodies were, donkey IgG
anti-goat fluorescein (FITC) labeled (1:60 dilution; Jackson
ImmunoResearch; Palo Alto, CA, USA), donkey IgG anti-mouse
TRITC labeled (1:60 dilution; Jackson ImmunoResearch; Palo
Alto, CA, USA), donkey IgG anti-rabbit FITC labeled (1:60
dilution; Sigma; St. Louis, MO, USA), and donkey IgG anti-rabbit
TRITC labeled (1:60 dilution; Jackson ImmunoResearch; Palo
Alto, CA, USA). After 5-min washing with PBS, the cells were
counterstaining with 1 mM Hoechst 33258, washed, and mounted
on glass slides using Vectashield (Vector Laboratories; Burlin-
game, CA, USA). The fluorescence was observed with a Leica
DMIRE2 microscope using 5X, 20X, or 40X objectives and the
filters A for Hoechst 33258, K3 for FITC. The images were
digitized with a Leica DC300F camera (Nussloch, Germany).
Negative controls were obtained by replacing the primary
antibody by an irrelevant antibody of the same IgG subclass.
Fluorescence labeling was also viewed through a multispectral
confocal laser-scanning microscope (TCS-SPE, Leica, Heidelberg)
using a 60X oil-immersion objective at excitation-emission
wavelengths of 405–465 nm (blue channel), 488–522 nm (green
channel), and 568–635 nm (red channel). Twenty to forty
consecutive optical sections at 0.3-mm intervals were obtained in
the z-series. The resulting images were projected on a bidimen-
sional plane and were overlapped on the screen monitor using blue
for Hoechst 33258, green for GFP and FITC, and red for TRITC.
The co-localization of TC with endoplasmic reticulum in Caco-
2 was further studied in electron microscope immunocytochem-
istry (transmission electron microscope Siemens 102). Cell pellets
were fixed and ultrathin sections were processed as described [33].
The anti-TC was used at a dilution of 1:25 and the secondary
antibody at 1:50 (Gold conjugate, anti-rabbit IgG, Ted Pella Inc.,
USA).
For the study of co-localization of megalin with reticulum in
Caco-2, we used a Leica TCS SP2-AOBS confocal microscope
(Leica Microsystems, Germany) equipped with an acousto-optical
beamsplitter, an argon laser (488 nm), an Helium Neon laser
(543 nm) were respectively used with an HCX APO L x40/0.8.
The bandwidths of the detected fluorescence wavelengths have
been optimized for each channel to the maximum emission (502–
530 for Alexa488 and 550–570 nm for Alexa555 respectively with
567 V and 463 V PMT Gain). All regular acquisitions were
collected at 400 Hz in sequential sequences to avoid potential cross
talking. Fluorescence emissions were recorded within 1 Airy disk
confocal pinhole opening and images at a 0. 238 mm (x, y) pixel
size were obtained for each case in 102461024 matrices (fields of
158,94 mm2). Mouse Anti-human Megalin is from Array Genetics
(USA). Rabbit anti-human calnexin (Sigma-Aldrich, France) was
used as a specific marker of reticulum in caco-2 cells.
Intracellular conversion of exogenous [57Co]-labelled
B12 (cyano-cobalamin, CN-Cbl)
Cells were plated onto 100 mm dishes.
57Co-labeled vitamin
B12 (11 MBq/nmol) was prepared and incorporated into culture
medium (0.37 pmol, 3.88 kBq/dish) and added in dishes contain-
ing 80–90% confluent cells, as described previously [8]. The final
concentration of B12 in medium was estimated to 100 pmol. The
loading was repeated every 24 hrs and cells were harvested for
HPLC analysis of CN-cobalamin, ado-cobalamin and methyl-
cobalamin after 72 hrs. The uptake of the radioactive B12 was
normalized to the protein content of each sample collected from
independent 100 mm dishes. The various forms of vitamin B12 in
cytosolic and mitochondria enriched fractions were analysed by
HPLC as described [8].
S-Adenosylmethionine (SAM) and S-
Adenosylhomocysteine (SAH)
the method was adapted from Miller et al. [34] as described
[35] and is based on a reverse phase high performance liquid
chromatography technique using a linear acetonitrile gradient.
Briefly, cell pellet was first washed with 1X PBS (Sigma) and then
lysed with the following lysis buffer: 0.05 M NaH2PO4 (pH 8),
0.15 M NaCl, 0.1 M Imidazole, 0.5% Chaps and Complete
TM
(Roche) Protease Inhibitors. The extracted proteins were precip-
itated with 3% HClO4 and centrifuged at 12,000 g at 4uC for 10
minutes. The supernatant was passed through a 0.45 mm filter
before injection into the column (LichrospherH, C18, OD 2.5 mm,
25064 mm I.D). The mobile phase was maintained at 30uC and
applied at a flow rate of 0.75 mL/min at 105 bars. It consisted of
50 mM sodium phosphate (pH 3.2), 10 mM heptan sulfonic acid
and acetonitrile (10 to 20% from 0 to 20 minutes). The amount of
SAM and SAH were quantified by absorbance at 254 nm.
Measurement of methionine synthase activity
Cells were seeded at a density of 6610
3 cells/cm
2 onto 100 mm
Petri dishes and cultured until confluence. Determination of
methionine synthase activity was performed by a modification of
the radioisotope assay described byWeissbach [36] and modified by
us [37]. In brief, cell lysates (1 mg) were homogenized at 4uCi n
0.5 ml of 0.1 M potassium phosphate buffer (pH 7.2) in the
presence of protease inhibitors. After centrifugation (10,000 g, 4uC)
for 3 min to remove cell debris, the supernatant was used as crude
extract. For measurement of apoenzyme activity, reaction mixture
contained 0.25 mM DL-homocysteine, 29 mM dithiotreitol (used
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adenosyl-methionine, 37 kBq (22 mM) [methyl-
14C]MeH4F, crude
extract and 50 mM potassium phosphate buffer in a total volume of
800 ml. The enzyme reaction was carried out under a N2
atmosphere at 37uC for 1 h in the dark and then stopped by
heating at 95uC for 5 min. The assay measures the amount of
radioactive methionine formed from 5-[
14C]methyl-THF and Hcy.
The mixture was passed through AG-1X8 (Cl-) columns (Bio-Rad,
Marnes-la-Coquette, France) and
14C radioactivity in the methio-
nine-containing fraction was measured. The radiolabeled methio-
nine wasmeasuredinaPackardliquidscintillationcounter.Enzyme
activity was expressed as nmoles of methionine produced per hour
per mg of proteins.
Statistics
All data were normally distributed and therefore expressed as
means6standard deviation (S.D.). The significance between the
various transfected cell lines and the effects of culture conditions
was determined by analysis of variance (ANOVA). In all analyses,
the null hypothesis was rejected at the 0.05 level.
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